Search research articles
Contact Us
Filters
Showing results (11-20 of 43) with videos related to
Page
of 5
Sort By:
Journal of Asthma and Allergy
|
October 31, 2023
BDP/FF NEXThaler to Improve Asthma Control Status in the Real World: The NEWTON Study
Fulvio Braido, Enrico Arnaboldi, Sara Barile, et al.
Respiratory Medicine
|
June 26, 2022
The 5T approach in asthma: Triple Therapy Targeting Treatable Traits
Mario Cazzola, Fulvio Braido, Luigino Calzetta, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
January 16, 2023
The impact of possible improper use on the performance in vitro of NEXThaler in comparison with Ellipta inhaler
Giada Varacca, Davide D'Angelo, Stefania Glieca, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 15, 2004
The prognostic value of residual mediastinal involvement following induction therapy and surgery for locally advanced non-small cell lung cancer
Stefano Margaritora, Alfredo Cesario, Domenico Galetta, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
October 17, 2018
Enlightening chronic obstructive pulmonary disease through patients' and caregivers' narratives
Valeria Gatti, Paolo Banfi, Stefano Centanni, et al.
Expert Opinion on Drug Delivery
|
June 20, 2020
Consequences of not-shaking and shake-fire delays on the emitted dose of some commercial solution and suspension pressurized metered dose inhalers
Veronica Chierici, Luca Cavalieri, Alessio Piraino, et al.
Scientific Reports
|
February 5, 2025
Single inhaler with beclometasone, formoterol, and glycopyrronium versus triple therapies in adults with uncontrolled asthma: a systematic review and meta-analysis
Fulvio Braido, Ioanna Vlachaki, Georgios F Nikolaidis, et al.
Respiratory Medicine
|
March 2, 2026
BDP/FF/GB single-inhaler triple therapy in COPD: real-world effectiveness, safety, and adherence in a pooled analysis of 5,000 patients
Guy Brusselle, Petros Bakakos, Daiana Stolz, et al.
The Lancet. Oncology
|
January 5, 2005
Symptom-free T4 lung cancer with bilateral pulmonary artery infiltration
Alfredo Cesario, Daniela Onorati, Vittorio Cardaci, et al.
International Journal of Pharmaceutics
|
December 19, 2022
No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs
Davide D'Angelo, Veronica Chierici, Eride Quarta, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 43) with videos related to
Sort By:
Page
of 5
Journal of Asthma and Allergy
|
October 31, 2023
BDP/FF NEXThaler to Improve Asthma Control Status in the Real World: The NEWTON Study
Fulvio Braido, Enrico Arnaboldi, Sara Barile, et al.
Respiratory Medicine
|
June 26, 2022
The 5T approach in asthma: Triple Therapy Targeting Treatable Traits
Mario Cazzola, Fulvio Braido, Luigino Calzetta, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
January 16, 2023
The impact of possible improper use on the performance in vitro of NEXThaler in comparison with Ellipta inhaler
Giada Varacca, Davide D'Angelo, Stefania Glieca, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 15, 2004
The prognostic value of residual mediastinal involvement following induction therapy and surgery for locally advanced non-small cell lung cancer
Stefano Margaritora, Alfredo Cesario, Domenico Galetta, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
October 17, 2018
Enlightening chronic obstructive pulmonary disease through patients' and caregivers' narratives
Valeria Gatti, Paolo Banfi, Stefano Centanni, et al.
Expert Opinion on Drug Delivery
|
June 20, 2020
Consequences of not-shaking and shake-fire delays on the emitted dose of some commercial solution and suspension pressurized metered dose inhalers
Veronica Chierici, Luca Cavalieri, Alessio Piraino, et al.
Scientific Reports
|
February 5, 2025
Single inhaler with beclometasone, formoterol, and glycopyrronium versus triple therapies in adults with uncontrolled asthma: a systematic review and meta-analysis
Fulvio Braido, Ioanna Vlachaki, Georgios F Nikolaidis, et al.
Respiratory Medicine
|
March 2, 2026
BDP/FF/GB single-inhaler triple therapy in COPD: real-world effectiveness, safety, and adherence in a pooled analysis of 5,000 patients
Guy Brusselle, Petros Bakakos, Daiana Stolz, et al.
The Lancet. Oncology
|
January 5, 2005
Symptom-free T4 lung cancer with bilateral pulmonary artery infiltration
Alfredo Cesario, Daniela Onorati, Vittorio Cardaci, et al.
International Journal of Pharmaceutics
|
December 19, 2022
No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs
Davide D'Angelo, Veronica Chierici, Eride Quarta, et al.
Page
of 5